Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Clinical Investigation

• Publication date

  1996-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI119006PMID 8903320PMCID PMC507645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor.

  1996cited by this paper
• Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor

  1996influential reference
• Comparative Analysis of Vascular Endothelial Growth Factor Receptors on Retinal and Aortic Vascular Endothelial Cells

  1995cited by this paper
• Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2.

  1995cited by this paper
• Hypoxic regulation of vascular endothelial growth factor in retinal cells.

  1995cited by this paper
• Definition of two angiogenic pathways by distinct alpha v integrins.

  1995cited by this paper
• Vascular Endothelial Cell Growth Factor Promotes Tyrosine Phosphorylation of Mediators of Signal Transduction That Contain SH2 Domains

  1995cited by this paper
• Definition of Two Angiogenic Pathways by Distinct αv Integrins

  1995cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia

  1994cited by this paper
• Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation

  1994cited by this paper
• Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase.

  1994cited by this paper
• Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3.

  1994cited by this paper
• Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

  1994influential reference
• Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues.

  1994cited by this paper
• Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

  1994cited by this paper
• Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells.

  1993cited by this paper
• Molecular and biochemical characterization of a recombinant human PKC-delta family member.

  1993cited by this paper
• High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

  1993cited by this paper
• Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation.

  1993cited by this paper
• Molecular and biochemical characterization of a recombinant human PKC-δ family member

  1993cited by this paper
• Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat.

  1992cited by this paper
• Phosphorylation of Nck in response to a variety of receptors, phorbol myristate acetate, and cyclic AMP

  1992cited by this paper
• Molecular and biological properties of the vascular endothelial growth factor family of proteins.

  1992cited by this paper
• Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

  1992cited by this paper
• Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C.

  1992influential reference
• The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.

  1992cited by this paper
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

  1992cited by this paper
• Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo

  1992cited by this paper
• Oncogenes and signal transduction.

  1991cited by this paper
• The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

  1991cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper
• Regulation of protein kinase C by nerve growth factor, epidermal growth factor, and phorbol esters in PC12 pheochromocytoma cells.

  1989cited by this paper
• Studies of inositol phospholipid-specific phospholipase C.

  1989influential reference
• Genistein, a specific inhibitor of tyrosine-specific protein kinases.

  1987cited by this paper
• Inositol 1,3,4,5-tetrakisphosphate and not phosphatidylinositol 3,4-bisphosphate is the probable precursor of inositol 1,3,4-trisphosphate in agonist-stimulated parotid gland.

  1986cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976influential reference
• A rapid method of total lipid extraction and purification.

  1959cited by this paper

• The role of VEGF in Cancer angiogenesis and tumorigenesis: Insights for anti-VEGF therapy.

  2025cites this paper
• Investigating the therapeutic potential of Apium graveolens linn. and Persea americana mill. seed extract in modulating cellular targets for the treatment of diabetic retinopathy

  2025cites this paper
• Traditional Chinese medicine in diabetic kidney disease: multifaceted therapeutic mechanisms and research progress

  2025cites this paper
• Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages.

  2024cites this paper
• Intravitreal OZURDEX vs. Intravitreal Bevacizumab for Diabetic Macular Edema: A Comprehensive Review

  2024cites this paper
• TM4SF1 is a molecular facilitator that distributes cargo proteins intracellularly in endothelial cells in support of blood vessel formation

  2024cites this paper
• The association of serum phospholipids levels with chronic kidney disease: A systematic review of observational studies

  2024cites this paper
• Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors

  2024cites this paper
• Tumor microenvironment signaling and therapeutics in cancer progression

  2023cites this paper
• Insulin Resistance Is an Alternative, Novel Risk Factor for Diabetes-Associated Periodontitis

  2023cites this paper
• Biology and therapeutic targeting of vascular endothelial growth factor A

  2023cites this paper
• Network pharmacology study of the mechanism underlying the therapeutic effect of Zhujing pill and its main component oleanolic acid against diabetic retinopathy

  2023cites this paper
• The thiophene α-terthienylmethanol isolated from Tagetes minuta inhibits angiogenesis by targeting protein kinase C isozymes α and β2

  2022cites this paper
• Connexin37 Regulates Cell Cycle in the Vasculature

  2022cites this paper
• Retinal Delivery of the Protein Kinase C-β Inhibitor Ruboxistaurin Using Non-Invasive Nanoparticles of Polyamidoamine Dendrimers

  2022cites this paper
• Hepatoprotective potential of flavonoid-rich extracts from Gongronema latifolium benth leaf in type 2 diabetic rats via fetuin-A and tumor necrosis factor-alpha

  2022cites this paper
• PREVALENCE, PATHOGENESIS, CLASSIFICATION, IMAGING, SCREENING AND MANAGE-MENT OF DIABETIC RETINOPATHY- A CRITICAL REVIEW

  2021cites this paper
• The Calcium Signaling Mechanisms in Arterial Smooth Muscle and Endothelial Cells.

  2021cites this paper
• Emerging roles of PLCγ1 in endothelial biology

  2021cites this paper
• Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema

  2021cites this paper
• Identification of a novel mutation in KIF11 with functional analysis in a cohort of 516 familial patients with exudative vitreoretinopathy

  2021cites this paper
• Regenerative Medicine and the Diabetic Foot

  2020cites this paper
• Molecular Tools for Metastatic Colorectal Cancer Characterization

  2020cites this paper
• Cytokines and Pathogenesis of Central Retinal Vein Occlusion

  2020cites this paper
• The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.

  2020cites this paper
• NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells

  2020cites this paper
• Diabetic Retinopathy: Important Biochemical Alterations and the Main Treatment Strategies.

  2020cites this paper
• Oxidative Stress and Vascular Dysfunction in the Retina: Therapeutic Strategies

  2020cites this paper
• PKCθ-JunB axis via upregulation of VEGFR3 expression mediates hypoxia-induced pathological retinal neovascularization

  2020cites this paper
• Endothelial Ca2+ Signaling, Angiogenesis and Vasculogenesis: Just What It Takes to Make a Blood Vessel

  2019cites this paper
• Brain Signalling Systems: A target for treating Type I Diabetes Mellitus.

  2019cites this paper
• Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion

  2019cites this paper
• α-Methyl-prednisolone normalizes the PKC mediated brain angiogenesis in dystrophic mdx mice.

  2019cites this paper
• Pathway Analysis Integrating Genome-Wide and Functional Data Identifies PLCG2 as a Candidate Gene for Age-Related Macular Degeneration

  2019cites this paper
• Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema

  2019cites this paper
• A unique protein kinase C‐dependent pathway for tissue factor downregulation in pericytes

  2019cites this paper
• Study the Acousto-Optic Spatial Filters Diffracted Light at Zeroth-Order Using MATLAB

  2018cites this paper
• Cytoprotective Effects of N-Acetylcysteine on Streptozotocin- Induced Oxidative Stress and Apoptosis in RIN-5F Pancreatic β-Cells

  2018cites this paper
• Diabetic macular oedema: under‐represented in the genetic analysis of diabetic retinopathy

  2018cites this paper
• Molecular pathobiology of Diabetic Retinopathy

  2018cites this paper
• Implications of MEK and VEGFR2 inhibition on melanoma CXCR4-CXCL12 chemotaxis, survival and tumour progression

  2017cites this paper
• Protein kinase C (PKC) involved in enhancement of α1-adrenoceptor-mediated responses of the main pulmonary artery in rats with diabetes mellitus

  2017cites this paper
• Coupling between the TRPC3 ion channel and the NCX1 transporter contributed to VEGF-induced ERK1/2 activation and angiogenesis in human primary endothelial cells.

  2017cites this paper
• A game changer for eye care for diabetes

  2017cites this paper
• Running title : TRPC 3 in VEGF-induced ERK 1 / 2 activation and angiogenesis

  2017cites this paper
• Predictors of proliferative diabetic retinopathy among patients with type 2 diabetes mellitus in Malaysia as detected by fundus photography

  2016cites this paper
• Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants

  2016cites this paper
• The Protein Kinase C Inhibitor: Ruboxistaurin.

  2016cites this paper
• Mechanisms and regulation of endothelial VEGF receptor signalling

  2016cites this paper
• A pharmacokinetic and safety study of a fixed oral dose of enzastaurin HCl in native Chinese patients with refractory solid tumors and lymphoma

  2016cites this paper
• The effects of green tea and pomegranate polyphenols on in vitro and in vivo VEGF activity

  2016cites this paper
• Analysis of the relationship between PM2.5 and lung cancer based on protein-protein interactions.

  2016cites this paper
• Plasma VEGF and IL-8 Levels in Patients with Mixed Dyslipidaemia. Effect of Rosuvastatin Monotherapy or its Combination at a Lower Dose with Omega-3 Fatty Acids: A Pilot Study.

  2016cites this paper
• BIOCHEMICAL BASIS AND EMERGING MOLECULAR TARGETS TO TREAT DIABETIC RETINOPATHY

  2016cites this paper
• A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma.

  2016cites this paper
• Disorders of Vascular Permeability.

  2016cites this paper
• Vascular Endothelial Growth Factor (VEGF) Promotes Assembly of the p130Cas Interactome to Drive Endothelial Chemotactic Signaling and Angiogenesis*

  2016cites this paper
• Intravitreal Triamcinolone Acetonide Therapy in Diabetic Macular Edema - Evaluation of the Effects of Metabolic Control, Serum Inflammatory Markers and Endothelial Factors

  2016cites this paper
• A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas

  2016cites this paper
• Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells

  2016cites this paper
• VEGF promotes assembly of the p 130 Cas interactome to drive endothelial chemotactic signalling and angiogenesis

  2016cites this paper
• A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of Ras

  2015influential citation
• Role of PKCδ in Insulin Sensitivity and Skeletal Muscle Metabolism

  2015cites this paper
• Oxygen and glucose deprivation on human Müller cells (MIO-M1) and human organotypic retinal cultures (HORCs) in relation to glaucoma

  2015cites this paper
• Targeting Protein Kinase C Downstream of Growth Factor and Adhesion Signalling

  2015cites this paper
• Epineural Patch Applications in Dorsal Root Ganglion Decompression Model

  2015cites this paper
• Protein Kinase C Beta in the Tumor Microenvironment Promotes Mammary Tumorigenesis

  2014cites this paper
• Molecularly targeted therapies for recurrent glioblastoma: current and future targets.

  2014cites this paper
• Metabotropic Glutamate Receptor-1 as a Novel Target for the Antiangiogenic Treatment of Breast Cancer

  2014cites this paper
• Diabetesmellitus(DM)isacomplexsyndromewhichleadstomultipledysfunctionsincludingvasculardisorders. Hyperglycemiaisconsideredtobeakeyfactorresponsibleforthedevelopmentofdiabeticvascularcomplications

  2014cites this paper
• Protein kinase C in enhanced vascular tone in diabetes mellitus.

  2014influential citation
• Effect of Bevacizumab and Ranibizumab on the Expression of eNOS in Trabecular Meshwork Cells

  2014cites this paper
• Novel therapies, including enzastaurin, in the treatment of ovarian cancer

  2014cites this paper
• Scutellarin Inhibits High Glucose–induced and Hypoxia-mimetic Agent–induced Angiogenic Effects in Human Retinal Endothelial Cells Through Reactive Oxygen Species/Hypoxia-inducible Factor-1&agr;/Vascular Endothelial Growth Factor Pathway

  2014cites this paper
• Improving developmental competence of in vitro produced porcine embryos using L-ascorbic acid and vascular endothelial growth factor A

  2014cites this paper
• Vascular endothelial growth factor-B in physiology and disease.

  2014cites this paper
• Inhibition de l'angiogenèse tumorale : criblage d'une chimiothèque et caractérisation d'un nouveau composé agissant sur la voie de signalisation Ras-ERK

  2014cites this paper
• The role and regulation of VEGF-mediated ERK5 activity in endothelial cells

  2014influential citation
• The influence of gender and sex hormones in the development of translational and experimental pulmonary arterial hypertension

  2014cites this paper
• Imaging Assessment of Lung Tumor Angiogenesis: Insights and Innovations

  2014cites this paper
• Role of Inflammation in Diabetic Macular Edema

  2014cites this paper
• Roles of PKC Isoforms in Development of Diabetes-Induced Cardiovascular Complications

  2014cites this paper
• PENTRAXIN 3 AND OTHER INFLAMMATORY FACTORS IN CENTRAL RETINAL VEIN OCCLUSION AND MACULAR EDEMA

  2014cites this paper
• Zinc finger MYND‐type containing 8 promotes tumour angiogenesis via induction of vascular endothelial growth factor‐A expression

  2014cites this paper
• Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets

  2014cites this paper
• Diabetische Retinopathie

  2014cites this paper
• Vascular endothelial growth factor

  2013cites this paper
• Role of PKCβ in Breast Cancer

  2013cites this paper
• SEVERITY OF DIABETIC RETINOPATHY IN RELATION WITH HEMOGLOBIN A1c AND SERUM LIPIDS

  2013cites this paper
• Chapter 46 – Diabetic Retinopathy: Genetics and Etiologic Mechanisms

  2013cites this paper
• Vascular endothelial growth factor in heart failure

  2013cites this paper
• Hypo- and Hyperglycemia Impair Endothelial Cell Actin Alignment and Nitric Oxide Synthase Activation in Response to Shear Stress

  2013cites this paper
• Angiogenesis and Vascularisation

  2013cites this paper
• Control of angiogenesis dictated by picomolar superoxide levels.

  2013cites this paper
• Protein Kinase C-eta Signalling in Breast Cancer

  2013cites this paper
• Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.

  2013cites this paper
• Analysing calcium dependent and independent regulation of eNOS in endothelium triggered by extracellular signalling events.

  2013cites this paper
• Function and histopathology after medication with rifabutin, inhibitors of vascular endothelial growth factors, triamcinolone and adalimumab

  2013cites this paper
• Protective Effect of Short-Term Genistein Supplementation on the Early Stage in Diabetes-Induced Renal Damage

  2013cites this paper
• Therapeutic applications of PI3K inhibitors in cardiovascular diseases.

  2013cites this paper